Drug Database
Back to search

Denmark· DK-28106070718

Abacavir/Lamivudine "Glenmark"

A lamivudine and abacavir product containing abacavirhydrochlorid, lamivudin, registered in Denmark by Glenmark Arzneimittel GmbH. The same ATC class is registered in 14 of our 19 countries.

ATC J05AR02

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedAbacavir/Lamivudine "Glenmark"ATCJ05AR02REGISTER NO.DK-28106070718PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about abacavirhydrochlorid, lamivudinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lamivudine and abacavir is registered in 14 of 19 countries.

Countries holding a registration under ATC J05AR02 (lamivudine and abacavir), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 9 of them publish a price we can compare per daily dose
Search lamivudine and abacavir products by name

Lamivudine and abacavir · ATC J05AR02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Abacavirhydrochlorid, LAMIVUDIN
Manufacturer
Glenmark Arzneimittel GmbH
Country
Denmark (DK)
ATC code
J05AR02
ATC class
Lamivudine and abacavir
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106070718

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for lamivudine and abacavir.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lamivudine and abacavir against other medicinesHow interaction checks work

Lamivudine and abacavir · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under J05AR02

Lamivudine and abacavir, as other registers publish it.

All lamivudine and abacavir products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa70bfaa-48b2-446d-a0c4-a9bbad70f84c
GET /v1/drugs/aa70bfaa-48b2-446d-a0c4-a9bbad70f84c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "600+300 mg",
  "auth_role": "CMS",
  "dk_drugid": "28106070718",
  "substance": "Abacavirhydrochlorid, LAMIVUDIN",
  "auth_procedure": "MRP",
  "in_medicinpriser": true,
  "registration_date_serial": "43255"
}
API referenceMCP serverPlans

See everything about lamivudine and abacavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console